The auto industry includes suppliers. The direct employees of GM, Ford, Chrysler, etc. are only part of the auto industry. Many suppliers would have had to go out of business if there was no GM to supply since GM is a large buyer of supplies. It would also have jeopardized U.S. security.
It's not cheaper and if insurers won't pay more of the cost, patients would have to pay more or not use the drug.
When a patent ends, there can be generics. Would GILD have to lower their anticipated prices to compete?
Are you delusional? I haven't even looked at AZO in years. As of then, AZO was buying stock back and there appeared to be financial engineering, as would be expected. I stayed away from SHLD and AZO ---same CEO. You love making accusations, even when you know they are ridiculous. Actually, maybe it's that you know or should know the accusations are ridiculous,, but it's your way of getting your "kicks." Not to worry, someone will have you banned from posting soon.
One institutional holder may try to keep it up, but another institutional holder or hedge fund manager appears to sell or short on each bounce.
When I see multiple overbought positions in one sentence (my only position in any of those is in CRM) I see irony. I don't know if it's intentional, but none of the above is a long at this time. I see a list of stocks that were once longs, but aren't now, IMHO. By Icahn, I don't know if you are refering to the position in his name or positions he has held recently.
Thank you for asking. Actually, I went long HUM from it's dip under 95 and exited Friday, the last market day before the end of the Medicare open season. Though I'd been out of CELG for awhile, I scalped it twice last week as it went from bounces over 66 to under 66 and then took a tiny long position, which I closed out this morning. I don't have a position in CELG. It's possible this morning's bounce in CELG was the top, but while news comes out, I'll stand aside from CELG.
Regarding CRM, it is trading uinder the 50 day MA and I remain negative about CRM. During 2013 a good part of CELG's and other companies' increases were due to stock buybacks. That action doesn't apply to CRM. In fact, CRM has added stock and that is bearish, IMHO.
How much value has the exiting officer taken out of the company and away from retail longs? Is this a sign that the shares handed out to employees now won't reap the profits that selling such shares has in the past?
When GILD puts a price on a drug and then zeroes out part of patients' co-pays, then isn't the price of the drug really lowered? When the reduction doesn't include Medicare patients, is Medicare likely to insist on the same or a similar price reduction? Will insurance companies limit use of the drug? I hope that people who want the drug to bring in more and more revenue realize that insurance companies that we want to keep premiums as low as possible may need to raise rates.
It doesn't matter whether you are paid or not, IMHO your predictions could push CRM up a little so institutions could unload. However, weakness in the market (that could even lead to changes in directions by IBD) and yet another analysis of shenanigans on another site are likely to nullify your projections. On a pre-split basis, CRM is close to dropping below the 200 mark, which is 50 here, IMHO. It may not be today or tomorrow, but it will by the end of 2013 and even before the Dec. 21 monthly options expiration (in which I have no position).
There is selling on any tiny bounce. CRM hasn't bounced as high as that resistance. Perhaps CRM would have in a very strong market, but it appears that there's some end of year selling (of many stocks) by money managers who are deciding it's too risky to wait a couple of weeks.
Are you falling for the incorrect % short shown on the statistics page or do you want others to fall for it? Also "rolled back the 12% gains of the previous month" is the beginning of the stock rolling over. I've seen that before in other stocks that fell much more after such action.
I don't have a position in JCP, but I think JCP is a less risky long than CRM. I'd have to review JCP (which I was short above 40, though I covered it too soon, not expecting it to go to 10 or so). JCP may not have GAAP earnings this quarter, but CRM won't have GAAP earnings for at least three years, (admitted by CEO) if ever..
There have been nine full trading days since the quarterly report. During that time CRM has dropped below the 50 day and may be on its way to the 200 day MA. This occurred during a time when market averages were up considerably. Despite the fact that bears have done better than bulls since before the quarterly report, it's possible those who pump the stock aren't actually long the stock.
The reversal of the DJIA and SPY's at the end of today, amid a few stocks holding up the QQQ, suggest the environment won't be as likely to favor increases in CRM's prices, especially since CRM is in no position to buy back stock, which has been a way some companies have supported their prices. Even that increase in stock prices for some due to buying back their stock may have done all it can. If those stocks back off even a little, CRM is likely to drop more.
So all you can do is post an old message about 100 shares and not only ignore that I posted shorting much higher than that, a few days before the most recent quarterly report? Pumps generally continue until there's more selling by institutions. When a stock drops from 50 to 20, will "talking heads" praise analysts who called the stock a sell when after it had dipped to 30?